Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-07

Clinical Trial Update: INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing INV-144 with Losartan in patients with hypertension and type 2 diabetes mellitus and macroalbuminuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INV-144
  • Losartan (losartan)

Snippet

Sponsor: InVasc Therapeutics, Inc. | Conditions: Hypertension, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED